Lee National Denim Day

share / bookmark page

Lee National Denim Day

Benefitting EIF's Women's Cancer Programs, Lee National Denim Day invites millions of Americans each year to slip on their favorite pair of jeans and donate just $5 to fight breast cancer.  Now in its 15th year, Lee National Denim Day has raised millions in support of cancer research, patient services, education and prevention.   

Money raised through Lee National Denim Day supports EIF’s Women’s Cancer Programs.   In 2009, EIF grants supported two distinct breast cancer research projects: one to fast-track more effective, less toxic treatments and increase patient access to some of the most significant clinical trials in the nation; and the other is a multi-year effort led by world-class scientists to develop a blood test for earlier detection of breast cancer when survival rates are the highest.   Donations also support grass roots efforts led by the National Breast Cancer Coalition and Christina Applegate’s Right Action For Women.

Less Toxic Treatments – Lee Laboratories  for Translational Research

Featured beneficiaries include:
Johns Hopkins University
Harvard University
Vanderbilt University
Baylor University
University of Chicago
University of California Los Angeles/Jonsson Comprehensive Cancer Center.

 

Early Detection – EIF Breast Cancer Biomarker Research Project

Featured beneficiaries include:

Institute for Systems Biology
Battelle/Pacific Northwest National Laboratory
University of Texas/M.D. Anderson Cancer Center
Fred Hutchinson Cancer Research Center
Broad Institute of Massachusetts Institute of Technology and Harvard
 

Grassroots Outreach  

National Breast Cancer Coalition offers individuals with breast cancer evidence-based information, and train advocates nationwide.  EIF grants support the development of a new interactive web site that makes it easy for individuals to navigate important information about the disease.  

Christina Applegate’s Right Action For Women educates women about what it means to be “high-risk” for breast cancer and is launching a pilot program to assist individuals at increased risk for breast cancer who cannot afford the high costs associated with breast screenings.